Putting your money where your mouth is, Royalty Pharma partners with J&J on $500M drug development deal Royalty Pharma plc (RPRX) announced a research and development co-funding agreement with Johnson & Johnson for $500 million over 2026 and 2027 to...
Rocket Pharmaceuticals stock gains on FDA gene therapy approval Rocket Pharmaceuticals (NASDAQ: RCKT) shares rose 6% Friday following the U.S. Food and Drug Administration’s accelerated approval of KRESLADI, the company’s gene therapy for pediatric patients with...
Yeilding results, U.S. Treasury yields touch highest since July as Trump extends key Iran deadline Benchmark U.S. Treasury yields jumped to their highest level since July on Friday, as investors assessed a fresh increase in oil prices despite President Donald...
Meanwhile across the pond, Soligenix receives EU orphan drug status for Behçet’s disease treatment Soligenix Inc. (NASDAQ: SNGX) announced that the European Commission granted orphan drug designation to dusquetide, the active ingredient in SGX945, for treating...
Crypto backed mortgages, Fannie Mae to Accept Crypto-backed Mortgage Fannie Mae is set to accept crypto-backed mortgages in a new partnership with Better Home & Finance and Coinbase, allowing borrowers to use cryptocurrencies as collateral for down payments...
